These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2873889)
1. Buspirone, Parkinson's disease, and the locus ceruleus. Ludwig CL; Weinberger DR; Bruno G; Gillespie M; Bakker K; LeWitt PA; Chase TN Clin Neuropharmacol; 1986; 9(4):373-8. PubMed ID: 2873889 [TBL] [Abstract][Full Text] [Related]
2. Buspirone in the treatment of tardive dyskinesia. Ross CA Med Hypotheses; 1987 Mar; 22(3):321-8. PubMed ID: 2884555 [TBL] [Abstract][Full Text] [Related]
3. Buspirone in Parkinson's disease. Hammerstad JP; Carter J; Nutt JG; Casten GC; Shrotriya RC; Alms DR; Temple D Clin Neuropharmacol; 1986; 9(6):556-60. PubMed ID: 3026624 [TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of buspirone and clorazepate in anxious outpatients. Cohn JB; Bowden CL; Fisher JG; Rodos JJ Am J Med; 1986 Mar; 80(3B):10-6. PubMed ID: 2870640 [TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. Feighner JP; Merideth CH; Hendrickson GA J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066 [TBL] [Abstract][Full Text] [Related]
6. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity. Sanghera MK; McMillen BA; German DC Eur J Pharmacol; 1982 Dec; 86(1):107-10. PubMed ID: 6130954 [TBL] [Abstract][Full Text] [Related]
14. The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity. Sanghera MK; German DC J Neural Transm; 1983; 57(4):267-79. PubMed ID: 6140300 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological and clinical effects of buspirone. Taylor DP; Eison MS; Riblet LA; Vandermaelen CP Pharmacol Biochem Behav; 1985 Oct; 23(4):687-94. PubMed ID: 2866549 [TBL] [Abstract][Full Text] [Related]
16. Buspirone and diazepam in anxiety: a controlled study. Rickels K; Weisman K; Norstad N; Singer M; Stoltz D; Brown A; Danton J J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078 [TBL] [Abstract][Full Text] [Related]
18. Buspirone: chemical profile of a new class of anxioselective agents. Temple DL; Yevich JP; New JS J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470 [TBL] [Abstract][Full Text] [Related]
19. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. Cohn JB; Wilcox CS J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128 [TBL] [Abstract][Full Text] [Related]
20. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Eison AS; Temple DL Am J Med; 1986 Mar; 80(3B):1-9. PubMed ID: 2870639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]